According to a recent study done by FMI, the corrosion inhibitors market is anticipated to have a prodigious CAGR of ...

Recent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK inhibitors unless there is no other alternative.

Proton pump inhibitors (PPIs), which are used to control acid reflux, are associated with an increased risk for migraine and other severe headache types, new research showed. Using data from the ...

Japan: A recent study published in Hypertension Research using nationwide real-world data demonstrated the potential ...

GYN, one of the worst-case scenarios runs like this: A woman comes in, overjoyed that she is finally pregnant after years of ...

AstraZeneca and Merck were the first to receive FDA approval for their PARP inhibitor Lynparza (olaparib) for use in breast ...

The essential premise of Zero Trust is that users must be verified every time they attempt to access information resources, not only at the point at which they sign in.

Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers groundbreaking treatment options for various diseases.

Acid reflux, characterised by the backflow of stomach acid into the esophagus, often leads to symptoms like heartburn and ...

Thomas W. Dubensky Jr., Ph.D., is a veteran biopharma executive and entrepreneur with a track record of strategic leadership in both private and public companies, ImmuneSensor said.

During a Case-Based Roundtable® event, Stanley M. Marks, MD, moderated a discussion on the impact of cardiac adverse events ...